Category Archives: Uncategorized

22 Oct

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap …

Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include

20 Oct

Abeona Therapeutics Appoints João Siffert Chief Medical Officer

João Siffert has been appointed head of research and development and chief medical officer of Abeona Therapeutics (NASDAQ: ABEO). As

19 Oct

Former Gilead Exec Kitty Yale Named Akero Chief Development Officer

Kitty Yale has been appointed chief development officer of Akero Therapeutics. She joins Akero from Gilead Sciences, where she was

19 Oct

Bioenergy conference: the impact of EU R&D funding – 25 October 2018, Brussels, Belgium

[Source: Research & Innovation] On 25 October 2018 a conference dedicated to bioenergy research, development and technologies will take place

19 Oct

Watchdog Report Reaffirms Concerns With Fail First

A new report by the Office of Inspector General at the U.S. Department of Health and Human Services (HHS) reaffirms

19 Oct

2018 BIO Investor Forum Wraps Up

As the stock market continued its volatile swings this week, investors at the BIO Investor Forum-which wrapped up today in

18 Oct

Exact Sciences Acquires San Diego Lab Equipment Supplier Biomatrica

Exact Sciences has gone from being a customer of Biomatrica, a San Diego-based vendor of equipment for storing and preserving

18 Oct

Call for proposals for ERC Proof of Concept Grant

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: ERC-2019-PoCPillar: Excellent ScienceOpening Date: Deadline: Thu, 25 Apr 2019 17:00:00 (Brussels local time)Modification Date: Thu, 18 Oct

18 Oct

On Track for a Record Breaking 2018 – #BIF18 Opening Plenary

Despite some recent market volatility, the industry is well positioned for long-term growth and success. That was the underlying theme

18 Oct

Nike’s Jim Scholefield Jumps to Merck to Lead Digital Strategy

Merck (NYSE: MRK) has appointed Jim Scholefield to serve as its chief information and digital officer. He starts his new